Kasra Khatibi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kasra Khatibi has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Satoshi Tateshima
David Geffen School of Medicine at UCLA
6 shared publications Gary Duckwiler
Affiliation Department of Radiology, University of California Los Angeles, Los Angeles, CA, United States of America
5 shared publicationsReza Jahan
Affiliation Department of Radiology, University of California Los Angeles, Los Angeles, CA, United States of America
5 shared publicationsViktor Szeder
Affiliation Department of Radiology, University of California Los Angeles, Los Angeles, CA, United States of America
5 shared publicationsMay Nour
Affiliations Department of Neurology, University of California Los Angeles, Los Angeles, CA, United States of America, Department of Radiology, University of California Los Angeles, Los Angeles, CA, United States of America
4 shared publicationsLucido Luciano Ponce Mejia
Affiliation Department of Neurosurgery, Louisiana State University, New Orleans, LA, United States of America
3 shared publications
Latest Publications
- 30 July 2023
- Published by BMJ
- Vol. 15  (Suppl 1) , A104.2-A105
E-048 Efficacy of asymmetric clot engagement for aspiration thrombectomy in distal vessel occlusion
Introduction/Purpose Recent data suggests that endovascular thrombectomy (EVT) may be beneficial in patients with acute ischemic stroke from distal vessel occlusion (DVO). The purpose of this study is to assess safety and efficacy of primary aspiration technique in patients with DVO. Materials and Methods This is a retrospective review of prospectively collected data of acute stroke patients at three institutions with DVO who underwent EVT between January 2021 and December 2022 with aspiration technique using Zoom catheters (0.071, 0.045, 0.055, and 0.035). DVO was defined as occlusion of mid and distal M2 or M3 segments of the middle cerebral artery, posterior cerebral artery, or anterior cerebral artery. The size of aspiration catheter was selected at the discretion of the primary interventionalist. Primary outcome measures included successful reperfusion (defined as TICI 2B or higher), number of passes, groin to recanalization time, and first pass effect. Secondary outcome measures included symptomatic intracranial hemorrhage (defined by ECASS II criteria), 90-day Modified Rankin Scale, and discharge NIHSS. Results A total of 50 patients (52% female, median age 67y (Interquartile range (IQR) 58-78)) with DVO who underwent EVT with aspiration technique were identified. Median presenting NIHSS was 11.5 (IQR 7-17). Location of occlusion included mid M2 (n=19, 38%), distal M2 (n=14, 28%), M3 (n=9, 18%), ACA (n=5, 10%), and PCA (n=3, 6%). Primary aspiration catheters utilized included Zoom 0.045 (n=16, 32.6%), Zoom 0.035 (n=12, 24.5%), Zoom 0.055 (n=12, 24.5%), and Zoom 0.071 (n=9, 18.4%). Successful recanalization was achieved in 49 (98%) patients. Median arterial puncture to final recanalization time was 24 minutes (IQR 14-37). Median number of passes was 1.5 [IQR 1-2]. First pass effect was achieved in 23 (50%) patients. Discharge NIHSS was available for 36/50 patients of which median discharge NIHSS was 3 (IQR 0.5-6.5). Only 1 (2%) patient experienced a symptomatic ICH. Conclusion Our findings suggest that aspiration thrombectomy with asymmetric clot engagement is safe and highly effective in patients with stroke from DVO. Disclosures D. Goldman: None. M. Al-Kawaz: None. V. Nguyen: None. J. Dallas: None. K. Khatibi: None. J. Scaggiante: None. K. Yaeger: None. T. Hardigan: None. C. Kellner: 1; C; Penumbra, Siemens. J. Fifi: 1; C; Stryker, Penumbra. 2; C; Stryker, Microvention, Penumbra, Cerenovus. 4; C; Endostream. S. Majidi: 2; C; Rapid Medical, Imperative Care, Cerenovus.
- 30 July 2023
- Published by BMJ
- Vol. 15  (Suppl 1) , A104.2-A105
E-048 Efficacy of asymmetric clot engagement for aspiration thrombectomy in distal vessel occlusion
Introduction/Purpose Recent data suggests that endovascular thrombectomy (EVT) may be beneficial in patients with acute ischemic stroke from distal vessel occlusion (DVO). The purpose of this study is to assess safety and efficacy of primary aspiration technique in patients with DVO. Materials and Methods This is a retrospective review of prospectively collected data of acute stroke patients at three institutions with DVO who underwent EVT between January 2021 and December 2022 with aspiration technique using Zoom catheters (0.071, 0.045, 0.055, and 0.035). DVO was defined as occlusion of mid and distal M2 or M3 segments of the middle cerebral artery, posterior cerebral artery, or anterior cerebral artery. The size of aspiration catheter was selected at the discretion of the primary interventionalist. Primary outcome measures included successful reperfusion (defined as TICI 2B or higher), number of passes, groin to recanalization time, and first pass effect. Secondary outcome measures included symptomatic intracranial hemorrhage (defined by ECASS II criteria), 90-day Modified Rankin Scale, and discharge NIHSS. Results A total of 50 patients (52% female, median age 67y (Interquartile range (IQR) 58-78)) with DVO who underwent EVT with aspiration technique were identified. Median presenting NIHSS was 11.5 (IQR 7-17). Location of occlusion included mid M2 (n=19, 38%), distal M2 (n=14, 28%), M3 (n=9, 18%), ACA (n=5, 10%), and PCA (n=3, 6%). Primary aspiration catheters utilized included Zoom 0.045 (n=16, 32.6%), Zoom 0.035 (n=12, 24.5%), Zoom 0.055 (n=12, 24.5%), and Zoom 0.071 (n=9, 18.4%). Successful recanalization was achieved in 49 (98%) patients. Median arterial puncture to final recanalization time was 24 minutes (IQR 14-37). Median number of passes was 1.5 [IQR 1-2]. First pass effect was achieved in 23 (50%) patients. Discharge NIHSS was available for 36/50 patients of which median discharge NIHSS was 3 (IQR 0.5-6.5). Only 1 (2%) patient experienced a symptomatic ICH. Conclusion Our findings suggest that aspiration thrombectomy with asymmetric clot engagement is safe and highly effective in patients with stroke from DVO. Disclosures D. Goldman: None. M. Al-Kawaz: None. V. Nguyen: None. J. Dallas: None. K. Khatibi: None. J. Scaggiante: None. K. Yaeger: None. T. Hardigan: None. C. Kellner: 1; C; Penumbra, Siemens. J. Fifi: 1; C; Stryker, Penumbra. 2; C; Stryker, Microvention, Penumbra, Cerenovus. 4; C; Endostream. S. Majidi: 2; C; Rapid Medical, Imperative Care, Cerenovus.
- Open Access
- 30 July 2023
- Published by BMJ
- Vol. 15  (Suppl 1) , A208.1-A208
E-217 Distal mechanical thrombectomy using beveled tip aspiration zoom 0.035’ microcatheters
Background Distal vessel occlusion (DVO) thrombectomy (M3, A2, P2, and beyond) has shown promising outcomes and safety profiles comparable to large vessel occlusion thrombectomy.1 Simple aspiration is associated with lower rates of symptomatic intracranial hemorrhage than stent-retriever.2 Novel, highly trackable bevel tipped .035 aspiration microcatheters (‘Zoom 0.035’) are promising for reperfusion of both de novo and rescue DVO thrombectomy. Methods This is a retrospective single-arm, multi-institutional observational study evaluating the efficacy and safety of aspiration thrombectomy for DVO using the Zoom .035 microcatheter. Information regarding patient demographics, presenting/discharge NIHSS, primary/rescue thrombectomy, site of occlusion, TICI score, and intracranial hemorrhage was chart abstracted. Descriptive statistics were used to evaluate the efficacy of thrombectomy both clinically and radiographically. Results Fifteen patients (8 male [53.3%]; mean age 65.5±14.0 years) underwent aspiration thrombectomy of DVO using the Zoom .035 microcatheter. The mean NIHSS at presentation was 11±5.3, and the mean ASPECTS was 9.1±0.9. Nine patients (60%) received tPA. Primary occlusion location was M3 in eleven cases (73.3%), V4 VA in one case (6.7%), A2 in one case (6.7%), A3 in one case (6.7%), and P1 in one case (6.7%). Rescue treatment (distal thrombectomy performed following aspiration of a more proximal lesion) occurred in 2/15 cases (13.3%), M3 in one case and P2 in the other. TICI scores were 3 in eight cases (53.3%), 2c in three case (20%), and 2b in four cases (26.7%). There was one postoperative SAH (6.7%) and one ICH (6.7%) that was asymptomatic. Mean discharge NIHSS was 1.9±2.7, with a mean decrease of 7.4±4.5 from presentation (pConclusion: Zoom .035 beveled-tip aspiration microcatheters are highly trackable and associated with improved radiographic and clinical outcomes for the treatment of DVO with a good safety profile. References Alawieh AM, Chalhoub RM, Al Kasab S, et al. Multicenter investigation of technical and clinical outcomes after thrombectomy for distal vessel occlusion by frontline technique. J Neurointerv Surg. 2022. Grieb D, Greling B, Schulz K, et al. Endovascular treatment of distal medium vessel occlusions using microcatheter aspiration thrombectomy. Interv Neuroradiol. 2022:15910199221133470. Disclosures V. Nguyen: None. J. Dallas: None. J. Sequeiros Chirinos: None. S. Graham: None. J. Burns-Martin: None. N. Goyal: None. K. Khatibi: None.
- 30 July 2023
- Published by BMJ
- Vol. 15  (Suppl 1) , A208.1-A208
Open AccessE-217 Distal mechanical thrombectomy using beveled tip aspiration zoom 0.035’ microcatheters
Background Distal vessel occlusion (DVO) thrombectomy (M3, A2, P2, and beyond) has shown promising outcomes and safety profiles comparable to large vessel occlusion thrombectomy.1 Simple aspiration is associated with lower rates of symptomatic intracranial hemorrhage than stent-retriever.2 Novel, highly trackable bevel tipped .035 aspiration microcatheters (‘Zoom 0.035’) are promising for reperfusion of both de novo and rescue DVO thrombectomy. Methods This is a retrospective single-arm, multi-institutional observational study evaluating the efficacy and safety of aspiration thrombectomy for DVO using the Zoom .035 microcatheter. Information regarding patient demographics, presenting/discharge NIHSS, primary/rescue thrombectomy, site of occlusion, TICI score, and intracranial hemorrhage was chart abstracted. Descriptive statistics were used to evaluate the efficacy of thrombectomy both clinically and radiographically. Results Fifteen patients (8 male [53.3%]; mean age 65.5±14.0 years) underwent aspiration thrombectomy of DVO using the Zoom .035 microcatheter. The mean NIHSS at presentation was 11±5.3, and the mean ASPECTS was 9.1±0.9. Nine patients (60%) received tPA. Primary occlusion location was M3 in eleven cases (73.3%), V4 VA in one case (6.7%), A2 in one case (6.7%), A3 in one case (6.7%), and P1 in one case (6.7%). Rescue treatment (distal thrombectomy performed following aspiration of a more proximal lesion) occurred in 2/15 cases (13.3%), M3 in one case and P2 in the other. TICI scores were 3 in eight cases (53.3%), 2c in three case (20%), and 2b in four cases (26.7%). There was one postoperative SAH (6.7%) and one ICH (6.7%) that was asymptomatic. Mean discharge NIHSS was 1.9±2.7, with a mean decrease of 7.4±4.5 from presentation (pConclusion: Zoom .035 beveled-tip aspiration microcatheters are highly trackable and associated with improved radiographic and clinical outcomes for the treatment of DVO with a good safety profile. References Alawieh AM, Chalhoub RM, Al Kasab S, et al. Multicenter investigation of technical and clinical outcomes after thrombectomy for distal vessel occlusion by frontline technique. J Neurointerv Surg. 2022. Grieb D, Greling B, Schulz K, et al. Endovascular treatment of distal medium vessel occlusions using microcatheter aspiration thrombectomy. Interv Neuroradiol. 2022:15910199221133470. Disclosures V. Nguyen: None. J. Dallas: None. J. Sequeiros Chirinos: None. S. Graham: None. J. Burns-Martin: None. N. Goyal: None. K. Khatibi: None.
- Open Access
- 4 May 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18  (5) , e0285082
Aneurysmal subarachnoid hemorrhage in pregnancy: National trends of treatment, predictors, and outcomes
Introduction: Aneurysmal subarachnoid hemorrhage (aSAH) is a rare event associated with significant pregnancy-associated maternal and neonatal morbidity and mortality. The optimal treatment strategy and clinical outcome of aSAH in pregnancy remains unclear. We aimed to investigate the treatment utilizations and outcomes of aSAH in pregnant people. Methods: Using the 2010–2018 National Inpatient Sample, we identified all birth hospitalizations of women between ages of 18 to 45 associated with subarachnoid hemorrhage and aneurysm treatment were included. Multivariate analyses were used to evaluate the effect of pregnancy state, mode of treatment of aneurysms, severity of subarachnoid hemorrhage on mortality and discharge destination of this cohort. Trends in mode of treatment utilized for aneurysmal treatment in this time interval was evaluated. Results: 13,351 aSAH with treatment were identified, of which 440 were associated with pregnancy. There was no significant difference in mortality or rate of discharge to home in pregnancy related hospitalization. Worse aSAH severity, chronic hypertension, and smaller hospital size was associated with significantly higher rate of mortality from aSAH during pregnancy. Worse aSAH severity was associated with lower rate of discharge to home. Like the non-pregnant cohort, the treatment of ruptured aneurysms in pregnancy are increasingly through endovascular approaches. The mode of treatment does not change the mortality or discharge destination. Conclusions: Pregnancy does not alter mortality or the discharge destination for aSAH. Ruptured aneurysms during pregnancy are increasingly treated endovascularly. Mode of aneurysm treatment does not affect mortality or discharge destination in pregnancy.
- 4 May 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18  (5) , e0285082
Open AccessAneurysmal subarachnoid hemorrhage in pregnancy: National trends of treatment, predictors, and outcomes
Introduction: Aneurysmal subarachnoid hemorrhage (aSAH) is a rare event associated with significant pregnancy-associated maternal and neonatal morbidity and mortality. The optimal treatment strategy and clinical outcome of aSAH in pregnancy remains unclear. We aimed to investigate the treatment utilizations and outcomes of aSAH in pregnant people. Methods: Using the 2010–2018 National Inpatient Sample, we identified all birth hospitalizations of women between ages of 18 to 45 associated with subarachnoid hemorrhage and aneurysm treatment were included. Multivariate analyses were used to evaluate the effect of pregnancy state, mode of treatment of aneurysms, severity of subarachnoid hemorrhage on mortality and discharge destination of this cohort. Trends in mode of treatment utilized for aneurysmal treatment in this time interval was evaluated. Results: 13,351 aSAH with treatment were identified, of which 440 were associated with pregnancy. There was no significant difference in mortality or rate of discharge to home in pregnancy related hospitalization. Worse aSAH severity, chronic hypertension, and smaller hospital size was associated with significantly higher rate of mortality from aSAH during pregnancy. Worse aSAH severity was associated with lower rate of discharge to home. Like the non-pregnant cohort, the treatment of ruptured aneurysms in pregnancy are increasingly through endovascular approaches. The mode of treatment does not change the mortality or discharge destination. Conclusions: Pregnancy does not alter mortality or the discharge destination for aSAH. Ruptured aneurysms during pregnancy are increasingly treated endovascularly. Mode of aneurysm treatment does not affect mortality or discharge destination in pregnancy.
- 3 November 2021
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 14  (4) , e3
Endovascular biopsy of a sigmoid sinus lesion using a stent retriever and aspiration catheter
A teenager with a history of acute myeloid leukemia presented with headache, nausea and blurry vision over a 2 week period. The MRI of the brain was concerning for the presence of a myeloid sarcoma within the right sigmoid sinus. For evaluation of venous obstruction and the underlying lesion the patient underwent a cerebral angiogram and transvenous biopsy of the sigmoid sinus lesion using a stent retriever and aspiration catheter. The tissue extracted was consistent with myeloid sarcoma. This pathologic finding was consistent with the recurrence of leukemia and guided the targeted oncologic treatment.
- 3 November 2021
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 14  (4) , e3
Endovascular biopsy of a sigmoid sinus lesion using a stent retriever and aspiration catheter
A teenager with a history of acute myeloid leukemia presented with headache, nausea and blurry vision over a 2 week period. The MRI of the brain was concerning for the presence of a myeloid sarcoma within the right sigmoid sinus. For evaluation of venous obstruction and the underlying lesion the patient underwent a cerebral angiogram and transvenous biopsy of the sigmoid sinus lesion using a stent retriever and aspiration catheter. The tissue extracted was consistent with myeloid sarcoma. This pathologic finding was consistent with the recurrence of leukemia and guided the targeted oncologic treatment.
- 6 January 2021
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 163  (4) , 1113-1119
Determinants of accuracy of freehand external ventricular drain placement by neurosurgical trainees
Background The external ventricular drain (EVD) placement is one of the most common neurosurgical procedures. This operation is performed by freehand technique in the majority of cases; therefore, the operator’s experience plays an important role in success and possible morbidity of this procedure. Objective To evaluate the accuracy and safety of EVD placement by junior neurosurgery residents and factors predicting accuracy of EVD placement. Methods This is a prospective cohort study conducted at our academic medical center, between September 2017 and August 2018. All patients 18 years or older who required EVD placement were included. The accuracy and complications of EVD placement were assessed in the first and second year resident cohorts as well as by their level of experience, using descriptive statistics. Univariate and multivariate models were used to assess predictive factors for optimal EVD. Results A total of 100 EVDs were placed in 100 patients during the study period. According to Kakarla classification, the catheter was optimally placed in 80% of cases. The first year residents had a significantly higher rate of suboptimal burr hole placement compared to the second year residents (66.7% versus 27.1%, p = 0.004). The trainees with less than 10 EVD placement experience also had a significantly higher rate of suboptimal burr hole placement (55.2% vs. 23.9%, p = 0.003), significantly longer duration of operation (43.1 min ± 14.9SD vs 34.2 min ± 9.6 p = 0.005), and significantly lower rate of optimal EVD location (85.9% versus 65.5%, p = 0.023). Optimal location of the burr hole was the only significant predictor of optimal EVD placement in multivariate analysis (OR 11.9, 95% CI 3.2–44.6, p < 0.001). Conclusions Neurosurgery residents experience and optimal burr hole placement are the main predicators of accurate EVD placement.
- 6 January 2021
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 163  (4) , 1113-1119
Determinants of accuracy of freehand external ventricular drain placement by neurosurgical trainees
Background The external ventricular drain (EVD) placement is one of the most common neurosurgical procedures. This operation is performed by freehand technique in the majority of cases; therefore, the operator’s experience plays an important role in success and possible morbidity of this procedure. Objective To evaluate the accuracy and safety of EVD placement by junior neurosurgery residents and factors predicting accuracy of EVD placement. Methods This is a prospective cohort study conducted at our academic medical center, between September 2017 and August 2018. All patients 18 years or older who required EVD placement were included. The accuracy and complications of EVD placement were assessed in the first and second year resident cohorts as well as by their level of experience, using descriptive statistics. Univariate and multivariate models were used to assess predictive factors for optimal EVD. Results A total of 100 EVDs were placed in 100 patients during the study period. According to Kakarla classification, the catheter was optimally placed in 80% of cases. The first year residents had a significantly higher rate of suboptimal burr hole placement compared to the second year residents (66.7% versus 27.1%, p = 0.004). The trainees with less than 10 EVD placement experience also had a significantly higher rate of suboptimal burr hole placement (55.2% vs. 23.9%, p = 0.003), significantly longer duration of operation (43.1 min ± 14.9SD vs 34.2 min ± 9.6 p = 0.005), and significantly lower rate of optimal EVD location (85.9% versus 65.5%, p = 0.023). Optimal location of the burr hole was the only significant predictor of optimal EVD placement in multivariate analysis (OR 11.9, 95% CI 3.2–44.6, p < 0.001). Conclusions Neurosurgery residents experience and optimal burr hole placement are the main predicators of accurate EVD placement.
- 1 November 2020
- Published by Wolters Kluwer Health in Stroke
- Vol. 51  (11) , 3241-3249
Reperfusion Therapy Frequency and Outcomes in Mild Ischemic Stroke in the United States
Background and Purpose: More than half of patients with acute ischemic stroke have minor neurological deficits; however, the frequency and outcomes of reperfusion therapy in regular practice has not been well-delineated. Methods: Analysis of US National Inpatient Sample of hospitalizations with acute ischemic stroke and mild deficits (National Institutes of Health Stroke Scale [NIHSS] score 0–5) from October 1, 2016, to December 31, 2017. Patient- and hospital-level characteristics associated with use and outcome of reperfusion therapies were analyzed. Primary outcomes included excellent discharge disposition (discharge to home without assistance); poor discharge disposition (discharge to facility or death); in-hospital mortality; and radiological intracranial hemorrhage. Results: Among 179 710 acute ischemic stroke admissions with recorded NIHSS during the 15-month study period, 103 765 (57.7%) had mild strokes (47.3% women; median age, 69 [interquartile range, 59–79] years; median NIHSS score of 2 [interquartile range, 1–4]). Considering reperfusion therapies among strokes with documented NIHSS, mild deficit hospitalizations accounted for 40.0% of IVT and 10.7% of mechanical thrombectomy procedures. Characteristics associated with IVT and with mechanical thrombectomy utilization were younger age, absence of diabetes, higher NIHSS score, larger/teaching hospital status, and Western US region. Excellent discharge outcome occurred in 48.2% of all mild strokes, and in multivariable analysis, was associated with younger age, male sex, White race, lower NIHSS score, absence of diabetes, heart failure, and kidney disease, and IVT use. IVT was associated with increased likelihood of excellent outcome (odds ratio, 1.90 [95% CI, 1.71–2.13], P P <0.001). Conclusions: In national US practice, more than one-half of acute ischemic stroke hospitalizations had mild deficits, accounting for 4 of every 10 IVT and 1 of every 10 mechanical thrombectomy treatments, and IVT use was associated with increased discharge to home despite increased intracranial hemorrhage.
- 1 November 2020
- Published by Wolters Kluwer Health in Stroke
- Vol. 51  (11) , 3241-3249
Reperfusion Therapy Frequency and Outcomes in Mild Ischemic Stroke in the United States
Background and Purpose: More than half of patients with acute ischemic stroke have minor neurological deficits; however, the frequency and outcomes of reperfusion therapy in regular practice has not been well-delineated. Methods: Analysis of US National Inpatient Sample of hospitalizations with acute ischemic stroke and mild deficits (National Institutes of Health Stroke Scale [NIHSS] score 0–5) from October 1, 2016, to December 31, 2017. Patient- and hospital-level characteristics associated with use and outcome of reperfusion therapies were analyzed. Primary outcomes included excellent discharge disposition (discharge to home without assistance); poor discharge disposition (discharge to facility or death); in-hospital mortality; and radiological intracranial hemorrhage. Results: Among 179 710 acute ischemic stroke admissions with recorded NIHSS during the 15-month study period, 103 765 (57.7%) had mild strokes (47.3% women; median age, 69 [interquartile range, 59–79] years; median NIHSS score of 2 [interquartile range, 1–4]). Considering reperfusion therapies among strokes with documented NIHSS, mild deficit hospitalizations accounted for 40.0% of IVT and 10.7% of mechanical thrombectomy procedures. Characteristics associated with IVT and with mechanical thrombectomy utilization were younger age, absence of diabetes, higher NIHSS score, larger/teaching hospital status, and Western US region. Excellent discharge outcome occurred in 48.2% of all mild strokes, and in multivariable analysis, was associated with younger age, male sex, White race, lower NIHSS score, absence of diabetes, heart failure, and kidney disease, and IVT use. IVT was associated with increased likelihood of excellent outcome (odds ratio, 1.90 [95% CI, 1.71–2.13], P P <0.001). Conclusions: In national US practice, more than one-half of acute ischemic stroke hospitalizations had mild deficits, accounting for 4 of every 10 IVT and 1 of every 10 mechanical thrombectomy treatments, and IVT use was associated with increased discharge to home despite increased intracranial hemorrhage.
- 1 November 2020
- Published by Elsevier in World Neurosurgery
- Vol. 143, 332-335
Targeted Radiation Therapy Can Treat Myxomatous Cerebral Aneurysms
- 1 November 2020
- Published by Elsevier in World Neurosurgery
- Vol. 143, 332-335
Targeted Radiation Therapy Can Treat Myxomatous Cerebral Aneurysms
- 1 September 2020
- Published by Elsevier in World Neurosurgery
- Vol. 141, e873-e879
In Vitro Modeling of Human Brain Arteriovenous Malformation for Endovascular Simulation and Flow Analysis
- 1 September 2020
- Published by Elsevier in World Neurosurgery
- Vol. 141, e873-e879
In Vitro Modeling of Human Brain Arteriovenous Malformation for Endovascular Simulation and Flow Analysis
- 1 July 2020
- Published by Elsevier in World Neurosurgery
- Vol. 139, e792-e799
Increased Rate of Successful First Passage Recanalization During Mechanical Thrombectomy for M2 Occlusion
- 1 July 2020
- Published by Elsevier in World Neurosurgery
- Vol. 139, e792-e799
Increased Rate of Successful First Passage Recanalization During Mechanical Thrombectomy for M2 Occlusion
- 1 September 2019
- Published by Elsevier in World Neurosurgery
- Vol. 129, e566-e571
Posterior Circulation Thrombectomy—pc-ASPECT Score Applied to Preintervention Magnetic Resonance Imaging Can Accurately Predict Functional Outcome
- 1 September 2019
- Published by Elsevier in World Neurosurgery
- Vol. 129, e566-e571
Posterior Circulation Thrombectomy—pc-ASPECT Score Applied to Preintervention Magnetic Resonance Imaging Can Accurately Predict Functional Outcome